GGenetics Read More Should You Buy Alphabet Inc. (GOOG) After Golden Cross? – July 28, 2025July 28, 2025 After reaching an important support level, Alphabet Inc. (GOOG Quick QuoteGOOG – Free Report) could be a good…
BBusiness Read More US Futures Climb After Trump Agrees EU Tariff Deal: Markets Wrap – Bloomberg.comJuly 28, 2025 US Futures Climb After Trump Agrees EU Tariff Deal: Markets Wrap Bloomberg.com Stock futures rise as U.S.-EU trade deal…
MMarkets Read More Return of Meme Stock Mania Has Traders on Alert for Market FrothJuly 27, 2025 The reemergence of meme stock mania last week has professional investors facing a quandary: ride the excitement of…
MMarkets Read More Global Money Chases World’s Hottest Major Stock Market in KoreaJuly 27, 2025 South Korean stocks, already this year’s best performers among the world’s major markets, are becoming a magnet for…
MMarkets Read More Singapore’s S$5 Billion Stock Market Revival Begins With a WhisperJuly 26, 2025 Each week we’ll bring you insights into one of Asia’s most dynamic economies. If you haven’t yet, please…
MMarkets Read More 3 Momentum Anomaly Picks as Markets Hit Record High on the Trot – July 25, 2025July 25, 2025 Key Takeaways NFLX surged 86.2% in a year but dipped 7.3% last week, earning a Momentum Score of…
MMarkets Read More All eyes on the U.S.: The dollar and labor marketJuly 23, 2025 The downward shift has been a gift to globally diversified U.S. investors. As the dollar weakened—triggered in part…
MMedication Read More Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New LawsuitJuly 19, 2025 A stockholder has filed a derivative lawsuit against the board of directors of Hims & Hers, the fast‑growing…
EEntrepreneurship Read More VC funding for Mass. startups drops to lowest in yearsJuly 16, 2025 It’s no secret that funding for tech startups is a lot harder to come by now than three…
GGenetics Read More FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock Tanks – July 14, 2025July 14, 2025 Key Takeaways CAPR’s BLA for deramiocel in DMD cardiomyopathy received an FDA complete response letter. The FDA cited…